Increasing Investment from Pharmaceutical Players Pushing Diabetes Market in China
Continuously increasing prevalence of diabetes led to growing demand of diabetes drugs. A lot of pharmaceutical players have been investing into research and development for insulin drug therapies. They have been investing in diabetic product portfolio and continuously making efforts to increase their market shares. Even the government organizations have been involved in various patient programs for introduction of technologically advanced delivery devices. Such type of awareness programs at government level or by pharmaceutical players increase the revenue from diabetes...
View full press release